EUVIMEDEUVIMED entdecken
Crossref

Duration of Clinical Response After In‐Office Steroid Injection for Vocal Fold Scar

Lucas G Axiotakis iD, Necati Enver, Evan L Kennedy, Kimberly A Duncan, Michael J Pitman iD

The Laryngoscope · 2023

DOI: 10.1002/lary.30539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2023. Verfasst von Lucas G Axiotakis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Voice and Swallowing, Department of Otolaryngology-Head and Neck Surgery, Columbia University Irving Medical Center, NewYork-Presbyterian …. Hauptthemen laut MEDLINE: Cicatrix, Steroids, Vocal Cords, Postoperative Complications. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the duration of clinical response after in‐office vocal fold steroid injection (VFSI) for vocal fold (VF) scar.

Methods

Demographic and clinical data for in‐office VFSI occurring from 2017 to 2020 were collected. Two Speech‐Language Pathologists (SLPs) used perceptual evaluation of voice and functional scales to evaluate blinded voice and laryngovideostroboscopy (LVS) samples collected pre‐ and post‐injection across multiple timepoints.

Results

Blinded SLP ratings were used for 30 individual VFs undergoing initial injection in 18 patients. Persistent improvement in voice past 6 months was seen in 57% of patients after VFSI. Multiple measures of voice and amplitude, percent vibrating tissue, and closed phase predominance significantly improved at various follow‐up timepoints on average.

Conclusion

Accounting for patient heterogeneity and disease progression, in‐office VFSI for VF scar is associated with sustained improvement in a subset of patients. Approximately half of patients can expect to experience a lasting improvement in voice. Future studies of larger scale are required to identify patient factors associated with long‐term benefit. Level of Evidence 4 Laryngoscope , 133:2333–2339, 2023

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CicatrixSteroidsVocal CordsPostoperative ComplicationsVoice DisordersHumansTreatment OutcomeVoice QualitySpeech-Language PathologyTime FactorsMaleFemaleYoung AdultAdultMiddle AgedAged

Stichwörter der Autor:innen

laryngologyvocal fold paralysis/paresis/motion impairmentvoice/dysphonia

Substanzen

Steroids

Autor:innen und Institutionen

  • Center for Voice and Swallowing, Department of Otolaryngology-Head and Neck Surgery, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York, USA.

ORCID-Profile: Lucas G Axiotakis, Michael J Pitman

Zitieren

APA

Axiotakis, L. G., Enver, N., Kennedy, E. L., Duncan, K. A., & Pitman, M. J. (2023). Duration of Clinical Response After In‐Office Steroid Injection for Vocal Fold Scar. The Laryngoscope. https://doi.org/10.1002/lary.30539

Vancouver

Axiotakis LG, Enver N, Kennedy EL, Duncan KA, Pitman MJ. Duration of Clinical Response After In‐Office Steroid Injection for Vocal Fold Scar. The Laryngoscope. 2023. doi:10.1002/lary.30539

BibTeX
@article{Axiotakis2023,
  author = {Axiotakis, Lucas G and Enver, Necati and Kennedy, Evan L and Duncan, Kimberly A and Pitman, Michael J},
  title = {Duration of Clinical Response After In‐Office Steroid Injection for Vocal Fold Scar},
  journal = {The Laryngoscope},
  year = {2023},
  doi = {10.1002/lary.30539}
}
Kostenlos starten →